about
c-Src control of chloride channel support for osteoclast HCl transport and bone resorptionIL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesisSoluble interleukin-6 receptor triggers osteoclast formation by interleukin 6RANK is essential for osteoclast and lymph node developmentTumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligandOsteoimmunology: interactions of the bone and immune systemGene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formationOsteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKLMesenchymal precursor cells in the blood of normal individualsEnhanced osteoclast development in collagen-induced arthritis in interferon-gamma receptor knock-out mice as related to increased splenic CD11b+ myelopoiesisBone loss. Factors that regulate osteoclast differentiation: an update.Bone loss. Therapeutic approaches for preventing bone loss in inflammatory arthritisThe molecular mechanism of osteoclastogenesis in rheumatoid arthritisMechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications.Unsatisfactory gene transfer into bone-resorbing osteoclasts with liposomal transfection systemsThe Modulatory Effects of Mesenchymal Stem Cells on OsteoclastogenesisCaldecrin: A pancreas-derived hypocalcemic factor, regulates osteoclast formation and functionThe Role of Hedgehog Signaling in Tumor Induced Bone DiseaseA review of denosumab for the treatment of osteoporosisHistorically significant events in the discovery of RANK/RANKL/OPGCrystal structure of the extracellular domain of mouse RANK ligand at 2.2-A resolutionTranscriptional mechanisms of bone morphogenetic protein-induced osteoprotegrin gene expressionCloning and initial characterization of mouse meltrin beta and analysis of the expression of four metalloprotease-disintegrins in bone cellsSinomenine suppresses osteoclast formation and Mycobacterium tuberculosis H37Ra-induced bone loss by modulating RANKL signaling pathwaysDownregulation of small GTPase Rab7 impairs osteoclast polarization and bone resorptionPossible role of direct Rac1-Rab7 interaction in ruffled border formation of osteoclastsImpaired bone resorption to prostaglandin E2 in prostaglandin E receptor EP4-knockout miceDeficiency of zebrafish fgf20a results in aberrant skull remodeling that mimics both human cranial disease and evolutionarily important fish skull morphologiesE Proteins and ID Proteins: Helix-Loop-Helix Partners in Development and DiseaseRab3D regulates a novel vesicular trafficking pathway that is required for osteoclastic bone resorption.Deletion of CD74, a putative MIF receptor, in mice enhances osteoclastogenesis and decreases bone massMacrophage migration inhibitory factor down-regulates the RANKL-RANK signaling pathway by activating Lyn tyrosine kinase in mouse modelsEstrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation.Cloning of the murine beta5 integrin subunit promoter. Identification of a novel sequence mediating granulocyte-macrophage colony-stimulating factor-dependent repression of beta5 integrin gene transcription.Cadherin-6 mediates the heterotypic interactions between the hemopoietic osteoclast cell lineage and stromal cells in a murine model of osteoclast differentiation.Gamma-glutamyltranspeptidase stimulates receptor activator of nuclear factor-kappaB ligand expression independent of its enzymatic activity and serves as a pathological bone-resorbing factor.Tie2 signaling regulates osteoclastogenesis and osteolytic bone invasion of breast cancer.Vitamin D3 differentially regulates parathyroid hormone/parathyroid hormone-related peptide receptor expression in bone and cartilage.Bone resorption induced by parathyroid hormone is strikingly diminished in collagenase-resistant mutant mice.The dectin 1 agonist curdlan regulates osteoclastogenesis by inhibiting nuclear factor of activated T cells cytoplasmic 1 (NFATc1) through Syk kinase.
P2860
Q24296702-32A8015E-FD82-4744-B4F8-540F306471DDQ24563235-4AC6ED1C-9EE1-4B19-9030-F98943804533Q24563585-F0C137A6-7E4D-4B7C-B15E-2F1FF1848A8CQ24598872-2DA6EC06-E408-4DAA-8DC4-C5204198EE0FQ24653311-6E57FE8D-B4DA-4533-947C-A73C1AADC91EQ24655113-717B30F7-3CFB-4BA7-BC6F-B13FCDEC3C6EQ24681552-C982A257-EDDF-41E7-A884-F2BE83AB5B9BQ24682139-9CBD61E7-BE00-4EFB-8FF3-8EF7E76F38D9Q24792739-31B27EDF-C7B9-4F79-9381-3D8E61B14FA8Q24800726-6D5A267A-2E74-41DD-BF74-B6CF68394B96Q24805142-1EED6D61-8709-4029-8190-04826E1B9838Q24805600-DC6E06B3-0432-4856-A1FC-4FD2D5129F32Q24806322-8E5484A6-D11F-4750-9137-D4B467BBD026Q24806684-1B5DA7F0-692C-4888-BF95-7C658B60AC7AQ24814004-BD520A13-13C8-49C4-AD9C-7030B1A6902BQ26773017-7AB1F6C7-5A17-4075-A710-77CE907851D7Q26775406-D85CEF82-7616-4642-9E02-4C609D8B5CD5Q26783615-58FCB23A-7AFD-4B5A-8048-226F4A3F52C0Q27005894-DF32471F-EB1A-4355-A995-21C27C43BEE9Q27027402-CBD8831C-180D-4B31-B21D-E050C3D86F3DQ27636573-DF421698-7A07-4392-8A69-B49497EBE073Q28141671-7C88C5F8-8B69-465D-B430-7FF97642A97AQ28261454-6DB28EB2-A231-4305-9262-691CBFDCD217Q28533497-1B012FBD-64BF-4EB9-A0EA-59FD3447876FQ28576916-71496734-2836-464E-B8B8-2FD4E700A088Q28584020-7BDD6ACA-0D44-4204-AE67-D625F15D3584Q28586541-24437CE4-1380-44B4-9DBB-E96165A8B7A3Q28660660-87BCD420-6DD2-4067-9169-9DD705CA12EDQ30054095-FA575746-3309-4616-ABE2-1F131F65C41BQ30475918-4676C215-8D05-4864-B8BB-53820E75BA22Q30534461-B85B0F2B-7C63-43BA-81AA-411C41604280Q30586409-483E6456-14C4-4D46-91E0-4553DAAC847BQ31717820-3601B63A-453B-45C7-8589-EB446394C421Q31938059-4006B9AC-6346-47FB-BAB2-6E1A6F5CADDAQ32060913-F945E60B-DD9E-4C21-A0E0-C9A46FE72469Q33195270-AC934F71-FD7B-45A3-9F36-C76489C3D970Q33767052-440897E9-6262-41DE-A023-E9A24EE03FFBQ33835523-C21D57E0-BA7A-4EB1-A8A5-B3CF758A7297Q33843025-AFE65983-5E03-4349-984E-3CA946CD3419Q33846556-4909D871-0477-4637-B78C-4B1539C093FE
P2860
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Modulation of osteoclast differentiation.
@ast
Modulation of osteoclast differentiation.
@en
type
label
Modulation of osteoclast differentiation.
@ast
Modulation of osteoclast differentiation.
@en
prefLabel
Modulation of osteoclast differentiation.
@ast
Modulation of osteoclast differentiation.
@en
P2093
P356
P1433
P1476
Modulation of osteoclast differentiation.
@en
P2093
P356
10.1210/EDRV-13-1-66
P577
1992-02-01T00:00:00Z